[![LegislationCrest](/images/crests/ukpga.gif)](/ukpga/2021/3/introduction/enacted?view=plain), 
# Medicines and Medical Devices Act 2021, 
# 2021 CHAPTER 3, 
An Act to make provision about a Commissioner for Patient Safety in relationto human medicines and medical devices; confer power to amend or supplementthe law relating to human medicines, veterinary medicines and medical devices;make provision about the enforcement of regulations, and the protection ofhealth and safety, in relation to medical devices; and for connected purposes., 
[11th February 2021], 
Be it enacted by the Queen’s most Excellent Majesty, by and with the adviceand consent of the Lords Spiritual and Temporal, and Commons, in this presentParliament assembled, and by the authority of the same, as follows:—, 
## PART 1The Commissioner for Patient Safety, 
### 1Establishment and core duties etc, 
(1)The Secretary of State must appoint a Commissioner for Patient Safety(referred to in this Part as “the Commissioner”) to exercise the functions setout in this Part in relation to England., 
(2)The Commissioner’s core duties are to—, 
(a)promote the safety of patients with regard to the use of medicines andmedical devices, and, 
(b)promote the importance of the views of patients and other members of thepublic in relation to the safety of medicines and medical devices., 
(3)The Commissioner is not to be regarded as the servant or agent of the Crownor as enjoying any status, immunity or privilege of the Crown., 
(4)Schedule 1 makes further provision about the Commissioner., 
## PART 2Human medicines, 
### CHAPTER 1Regulations, 
#### 2Power to make regulations about human medicines, 
(1)The appropriate authority may by regulations make provision specified insections 3 to 7 amending or supplementing the law relating to human medicines., 
(2)In making regulations under subsection (1), the appropriate authority’soverarching objective must be safeguarding public health., 
(3)In considering whether regulations under subsection (1) would contribute tothis objective, the appropriate authority must have regard to—, 
(a)the safety of human medicines;, 
(b)the availability of human medicines;, 
(c)the likelihood of the relevant part of the United Kingdom being seen as afavourable place in which to—, 
(i)carry out research relating to human medicines,, 
(ii)conduct clinical trials, or, 
(iii)manufacture or supply human medicines., 
(4)Where regulations under subsection (1) may have an impact on the safety ofhuman medicines, the appropriate authority may make the regulations only ifthe authority considers that the benefits of doing so outweigh the risks., 
(5)In subsection (3)(c), “relevant part of the United Kingdom” means—, 
(a)so far as the regulations relate to England and Wales and Scotland, thoseparts of the United Kingdom, and, 
(b)so far as the regulations relate to Northern Ireland, that part of theUnited Kingdom., 
(6)In this Part, “appropriate authority” means—, 
(a)in relation to England and Wales and Scotland, the Secretary of State, and, 
(b)in relation to Northern Ireland—, 
(i)the Department of Health in Northern Ireland, or, 
(ii)the Department of Health in Northern Ireland and the Secretary of Stateacting jointly., 
#### 3Manufacture, marketing and supply, 
(1)Regulations under section 2(1) may make provision about—, 
(a)authorisations to manufacture human medicines,, 
(b)authorisations to import human medicines,, 
(c)authorisations to distribute human medicines by way of wholesale dealing,, 
(d)marketing authorisations,, 
(e)manufacturing, importing or distributing active substances,, 
(f)brokering in relation to human medicines,, 
(g)the registration of the premises of pharmacy businesses,, 
(h)the recording of information about the supply of human medicines,, 
(i)notification and reporting requirements in relation to human medicines thathave been placed on the market,, 
(j)the labelling and packaging of human medicines or the information that mustbe supplied with them or made available in relation to them,, 
(k)advertising with regard to human medicines,, 
(l)the registration of persons who supply or offer to supply human medicinesby means of the internet,, 
(m)the requirements that must be met in relation to a prescription,, 
(n)prohibitions in the provisions mentioned in subsection (2), or, 
(o)the use of tissues or cells (within the meanings given by regulation 5(1)of the Human Tissue (Quality and Safety for Human Application) Regulations2007 ([S.I. 2007/1523](/id/uksi/2007/1523?view=plain "Go to item oflegislation"))) in relation to human medicines., 
(2)Subsection (1)(n) refers to the following provisions in the Human MedicinesRegulations 2012 ([S.I. 2012/1916](/id/uksi/2012/1916?view=plain "Go to itemof legislation"))—, 
(a)regulation 214 and Schedule 13 (sale or supply of prescription onlymedicines),, 
(b)regulation 215 and Schedule 14 (prescribing and administration bysupplementary prescribers),, 
(c)regulation 220 (sale or supply of human medicines not subject to generalsale),, 
(d)regulation 221 and Schedule 15 (sale or supply of medicinal productssubject to general sale), and, 
(e)regulation 249 and Schedule 22 (restrictions on persons to be supplied withmedicinal products)., 
#### 4Falsified medicines, 
(1)Regulations under section 2(1) may make provision about—, 
(a)the prevention of the supply of falsified human medicines, or, 
(b)the use, retention and disclosure, for any purpose to do with humanmedicines, of information collected for the purpose of preventing the supplyof falsified human medicines., 
(2)Provision made in reliance on subsection (1)(a) may (among other things)make provision—, 
(a)for human medicines that are subjects of a marketing authorisation to besupplied in packs that—, 
(i)carry unique identifiers associated with the products, and, 
(ii)are protected with anti-tamper devices,, 
(b)for checks to be carried out in relation to packs that have or should havesuch a unique identifier,, 
(c)about the infrastructure, systems and processes required for the allocationand checking of unique identifiers, including provision about—, 
(i)who is to set up the infrastructure, systems and processes,, 
(ii)who is to maintain them, and, 
(iii)who is to pay for them., 
(3)In making regulations in reliance on subsection (1), the appropriateauthority must have regard to the importance of ensuring that information isretained securely., 
#### 5Clinical trials, 
(1)Regulations under section 2(1) may make provision—, 
(a)corresponding or similar to provision in the EU Clinical Trials Regulation,, 
(b)about authorisations concerning clinical trials in the United Kingdom,including applications for an assessment of the ethics of a proposed clinicaltrial,, 
(c)about notification and reporting requirements in relation to clinicaltrials,, 
(d)about requirements that must be met before a clinical trial may be carriedout, or, 
(e)relating to the conduct of clinical trials., 
(2)In subsection (1)(a), “EU Clinical Trials Regulation” means [Regulation(EU) No 536/2014](/european/regulation/2014/0536?view=plain "Go to item oflegislation") of the European Parliament and of the Council of 16 April 2014on clinical trials on medicinal products for human use, and repealing[Directive 2001/20/EC](/european/directive/2001/0020?view=plain "Go to item oflegislation")., 
#### 6Fees, offences, powers of inspectors, 
(1)Regulations under section 2(1) may make provision—, 
(a)about the charging of fees in connection with the exercise of a functionconferred by a human medicines provision,, 
(b)creating a criminal offence of failing to comply with a provision made inthe regulations, or, 
(c)applying relevant powers of entry or other powers of inspectors with orwithout modification in relation to a prohibition or requirement in provisionmade in the regulations., 
(2)Regulations under section 2(1) may not provide for an offence to bepunishable with a sentence of imprisonment of more than two years., 
(3)In subsection (1), “relevant powers of entry or other powers of inspectors”means powers of entry or powers of inspectors in—, 
(a)Part 8 of the Medicines Act 1968;, 
(b)the Medicines for Human Use (Clinical Trials) Regulations 2004 ([S.I.2004/1031](/id/uksi/2004/1031?view=plain "Go to item of legislation"));, 
(c)Part 16 of the Human Medicines Regulations 2012 ([S.I.2012/1916](/id/uksi/2012/1916?view=plain "Go to item of legislation"))., 
(4)In this Part, “human medicines provision” means a provision in—, 
(a)regulations under section 2(1),, 
(b)the Human Medicines Regulations 2012, or, 
(c)the Medicines for Human Use (Clinical Trials) Regulations 2004., 
#### 7Emergencies, 
(1)Regulations under section 2(1) may make provision about the disapplicationof a human medicines provision in circumstances which give rise to a need toprotect the public from a risk of serious harm to health., 
(2)Regulations made in reliance on subsection (1) may provide for thedisapplication to be subject to—, 
(a)conditions set out in the regulations;, 
(b)conditions set out in a protocol published by the appropriate authority., 
(3)Where regulations made in reliance on subsection (1) provide that theappropriate authority may publish a protocol setting out conditions, theregulations must provide—, 
(a)that the appropriate authority may withdraw or amend the protocol, and, 
(b)that the protocol is to have effect only for a period of time specified inthe protocol., 
### CHAPTER 2International agreements: disclosure of information, 
#### 8Disclosure of information in accordance with international agreements, 
(1)This section applies to information which a relevant authority holds inconnection with human medicines., 
(2)The relevant authority may disclose information to a relevant personoutside the United Kingdom where—, 
(a)the disclosure is required for the purpose of giving effect to aninternational agreement or arrangement concerning the regulation of humanmedicines, and, 
(b)the relevant authority considers that the disclosure is in the publicinterest., 
(3)The relevant authority may not disclose commercially sensitive informationin reliance on subsection (2) unless the relevant authority—, 
(a)considers that it is necessary to do so for the purpose mentioned in thatsubsection, and, 
(b)is satisfied that the making of the disclosure is proportionate to what issought to be achieved by it., 
(4)Except as provided by subsections (5) and (6), the disclosure ofinformation in accordance with this section does not breach—, 
(a)an obligation of confidence owed by the person making the disclosure, or, 
(b)any other restriction on the disclosure of the information (howeverimposed)., 
(5)Nothing in this section authorises a disclosure of patient informationwithout the consent of the individual to whom that information relates., 
(6)Nothing in this section authorises a disclosure of information which—, 
(a)contravenes the data protection legislation (but in determining whether adisclosure would do so, take into account the powers conferred by thissection), or, 
(b)is prohibited by any of Parts 1 to 7 or Chapter 1 of Part 9 of theInvestigatory Powers Act 2016., 
(7)This section does not limit the circumstances in which information may bedisclosed under any other enactment or rule of law., 
(8)In this section—, 
  * “commercially sensitive information” means commercial information whose disclosure the relevant authority thinks might significantly harm the legitimate business interests of the undertaking to which it relates; , 
  * “data protection legislation” has the meaning given by section 3(9) of the Data Protection Act 2018; , 
  * “patient information” means information (however recorded) which— , 
(a), 
relates to—, 
(i), 
the physical or mental health or condition of an individual,, 
(ii), 
the diagnosis of an individual’s condition, or, 
(iii), 
an individual’s care or treatment,, 
or is (to any extent) derived directly or indirectly from information relatingto any of those matters, and, 
(b), 
identifies the individual or enables the individual to be identified (whetherby itself or in combination with other information);, 
  * “relevant authority” means— , 
(a), 
the Secretary of State, or, 
(b), 
the Department of Health in Northern Ireland;, 
  * “relevant person” means— , 
(a), 
the government of a country or territory outside the United Kingdom;, 
(b), 
a person who exercises functions on behalf of such a government;, 
(c), 
any other person who exercises functions or provides services relating tohuman medicines in a country or territory outside the United Kingdom;, 
(d), 
an international organisation that exercises functions or provides servicesrelating to human medicines., 
### CHAPTER 3Interpretation, 
#### 9Interpretation of Part 2, 
In this Part—, 
  * “active substance” has the meaning given by regulation 8 of the Human Medicines Regulations 2012 ([S.I. 2012/1916](/id/uksi/2012/1916?view=plain "Go to item of legislation")); , 
  * “appropriate authority” has the meaning given by section 2(6); , 
  * “clinical trial” has the meaning given by regulation 2(1) of the Medicines for Human Use (Clinical Trials) Regulations 2004 ([S.I. 2004/1031](/id/uksi/2004/1031?view=plain "Go to item of legislation")); , 
  * “EU Clinical Trials Regulation” has the meaning given by section 5(2); , 
  * “falsified human medicine” means a falsified medicinal product within the meaning given by regulation 8 of the Human Medicines Regulations 2012; , 
  * “human medicine” means a medicinal product within the meaning given by regulation 2 of the Human Medicines Regulations 2012; , 
  * “human medicines provision” has the meaning given by section 6(4); , 
  * “law relating to human medicines” means— , 
(a), 
sections 10 and 15, and Part 4, and section 131 of the Medicines Act 1968(which make provision relating to pharmacies),, 
(b), 
the Human Medicines Regulations 2012,, 
(c), 
the Medicines for Human Use (Clinical Trials) Regulations 2004, and, 
(d), 
the Medicines (Products for Human Use) (Fees) Regulations 2016 ([S.I.2016/190](/id/uksi/2016/190?view=plain "Go to item of legislation"));, 
  * “manufacture” includes assembly; , 
  * “marketing authorisation” means an authorisation to market a human medicine in the United Kingdom; , 
  * “pharmacy business” means a business (other than a professional practice carried on by a doctor or dentist) which consists of or includes the sale of medicinal products that are not subject to general sale; , 
  * “supplying” includes administering within the meaning given by regulation 8 of the Human Medicines Regulations 2012 (and related expressions are to be read accordingly). , 
## PART 3Veterinary medicines, 
### CHAPTER 1Regulations, 
#### 10Power to make regulations about veterinary medicines, 
(1)The appropriate authority may by regulations make provision specified insections 11 and 12 amending or supplementing the Veterinary MedicinesRegulations 2013 ([S.I. 2013/2033](/id/uksi/2013/2033?view=plain "Go to itemof legislation"))., 
(2)In making regulations under subsection (1), the appropriate authority’soverarching objective must be to promote one or more of the following—, 
(a)the health and welfare of animals;, 
(b)the health and safety of the public;, 
(c)the protection of the environment., 
(3)In considering whether regulations under subsection (1) would contribute tothis objective, the appropriate authority must have regard to—, 
(a)the safety of veterinary medicines;, 
(b)the availability of veterinary medicines;, 
(c)the likelihood of the relevant part of the United Kingdom being seen as afavourable place in which to—, 
(i)develop veterinary medicines, or, 
(ii)manufacture or supply veterinary medicines., 
(4)Where regulations under subsection (1) may have an impact on the safety ofveterinary medicines, the appropriate authority may make the regulations onlyif the authority considers that the benefits of doing so outweigh the risks., 
(5)In subsection (3)(c), “relevant part of the United Kingdom” means—, 
(a)so far as the regulations relate to England and Wales and Scotland, thoseparts of the United Kingdom, and, 
(b)so far as the regulations relate to Northern Ireland, that part of theUnited Kingdom., 
(6)In this Part, “appropriate authority” means—, 
(a)in relation to England and Wales and Scotland, the Secretary of State, and, 
(b)in relation to Northern Ireland—, 
(i)the Department of Agriculture, Environment and Rural Affairs in NorthernIreland, or, 
(ii)the Department of Agriculture, Environment and Rural Affairs in NorthernIreland and the Secretary of State acting jointly., 
#### 11Manufacture, marketing, supply and field trials, 
(1)Regulations under section 10(1) may make provision about—, 
(a)authorisations to manufacture veterinary medicines,, 
(b)authorisations to import veterinary medicines,, 
(c)authorisations to distribute veterinary medicines by way of wholesaledealing,, 
(d)marketing authorisations,, 
(e)marketing, importing or distributing active substances,, 
(f)the categories of person who may supply veterinary medicines,, 
(g)requirements that must be met in relation to the supply of veterinarymedicines,, 
(h)the registration of persons who supply or offer to supply veterinarymedicines by means of the internet,, 
(i)the circumstances in which veterinary medicines may be administered,, 
(j)notification and reporting requirements in relation to veterinary medicines(or things purporting to be veterinary medicines) that have been placed on themarket,, 
(k)the labelling and packaging of veterinary medicines or the information thatmust be supplied with them or made available in relation to them,, 
(l)advertising with regard to veterinary medicines, or, 
(m)animal test certificates granted under the Veterinary Medicines Regulations2013 ([S.I. 2013/2033](/id/uksi/2013/2033?view=plain "Go to item oflegislation")) for research purposes., 
(2)Regulations under section 10(1) may make provision corresponding or similarto provision in the following EU Regulations—, 
(a)[Regulation (EU) 2019/4](/european/regulation/2019/0004?view=plain "Go toitem of legislation") of the European Parliament and of the Council of 11December 2018 on the manufacture, placing on the market and use of medicatedfeed, amending Regulation [(EC) No183/2005](/european/regulation/2005/0183?view=plain "Go to item oflegislation") of the European Parliament and of the Council and repealingCouncil Directive [90/167/EEC](/european/directive/1990/0167?view=plain "Go toitem of legislation");, 
(b)[Regulation (EU) 2019/6](/european/regulation/2019/0006?view=plain "Go toitem of legislation") of the European Parliament and of the Council of 11December 2018 on veterinary medicinal products and repealing [Directive2001/82/EC](/european/directive/2001/0082?view=plain "Go to item oflegislation")., 
#### 12Fees, offences, powers of inspectors, costs, 
(1)Regulations under section 10(1) may make provision—, 
(a)about the charging of fees in connection with the exercise of a functionconferred by a veterinary medicines provision,, 
(b)creating a criminal offence of failing to comply with a provision made inthe regulations,, 
(c)applying powers of entry or other powers of an inspector in the VeterinaryMedicines Regulations 2013 ([S.I. 2013/2033](/id/uksi/2013/2033?view=plain "Goto item of legislation")) with or without modification in relation to aprohibition or requirement in provision made in regulations under section10(1), or, 
(d)about the recovery of costs incurred in the administration of improvementnotices or seizure notices under the Veterinary Medicines Regulations 2013(see regulations 38 and 41)., 
(2)Regulations under section 10(1) may not provide for an offence to bepunishable with a sentence of imprisonment of more than two years., 
(3)Regulations applying powers of entry in reliance on subsection (1)(c) maynot confer a power of entry in respect of premises used wholly or mainly as aprivate dwelling unless those premises, or any part of them, are approved,registered or authorised for the sale or supply of veterinary medicines undera veterinary medicines provision., 
(4)In this section, “veterinary medicines provision” means a provision in—, 
(a)regulations under section 10(1), or, 
(b)the Veterinary Medicines Regulations 2013., 
### CHAPTER 2International agreements: disclosure of information, 
#### 13Disclosure of information in accordance with international agreements, 
(1)This section applies to information which a relevant authority holds inconnection with veterinary medicines., 
(2)The relevant authority may disclose information to a relevant personoutside the United Kingdom where—, 
(a)the disclosure is required for the purpose of giving effect to aninternational agreement or arrangement concerning the regulation of veterinarymedicines, and, 
(b)the relevant authority considers that the disclosure is in the publicinterest., 
(3)The relevant authority may not disclose commercially sensitive informationin reliance on subsection (2) unless the relevant authority—, 
(a)considers that it is necessary to do so for the purpose mentioned in thatsubsection, and, 
(b)is satisfied that the making of the disclosure is proportionate to what issought to be achieved by it., 
(4)Except as provided by subsection (5), the disclosure of information inaccordance with this section does not breach—, 
(a)an obligation of confidence owed by the person making the disclosure, or, 
(b)any other restriction on the disclosure of the information (howeverimposed)., 
(5)Nothing in this section authorises a disclosure of information which—, 
(a)contravenes the data protection legislation (but in determining whether adisclosure would do so, take into account the powers conferred by thissection), or, 
(b)is prohibited by any of Parts 1 to 7 or Chapter 1 of Part 9 of theInvestigatory Powers Act 2016., 
(6)This section does not limit the circumstances in which information may bedisclosed under any other enactment or rule of law., 
(7)In this section—, 
  * “commercially sensitive information” means commercial information whose disclosure the relevant authority thinks might significantly harm the legitimate business interests of the undertaking to which it relates; , 
  * “data protection legislation” has the meaning given by section 3(9) of the Data Protection Act 2018; , 
  * “relevant authority” means— , 
(a), 
the Secretary of State, or, 
(b), 
the Department of Agriculture, Environment and Rural Affairs in NorthernIreland;, 
  * “relevant person” means— , 
(a), 
the government of a country or territory outside the United Kingdom;, 
(b), 
a person who exercises functions on behalf of such a government;, 
(c), 
any other person who exercises functions or provides services relating toveterinary medicines in a country or territory outside the United Kingdom;, 
(d), 
an international organisation that exercises functions or provides servicesrelating to veterinary medicines., 
### CHAPTER 3Interpretation etc, 
#### 14Interpretation of Part 3 and supplementary provision, 
(1)In this Part—, 
  * “active substance” means any substance or mixture of substances intended to be used in the manufacture of a veterinary medicine that, when used in its production, becomes an active ingredient of that medicine; , 
  * “appropriate authority” has the meaning given by section 10(6); , 
  * “manufacture” includes assembly; , 
  * “marketing authorisation” means an authorisation to market a veterinary medicine in the United Kingdom; , 
  * “veterinary medicine” means a veterinary medicinal product within the meaning given by regulation 2 of the Veterinary Medicines Regulations 2013 ([S.I. 2013/2033](/id/uksi/2013/2033?view=plain "Go to item of legislation")). , 
(2)In the Animals (Scientific Procedures) Act 1986, in section 2 (regulatedprocedures), in subsection (8)(d), after “the Veterinary Medicines Regulations2011” insert “or the Veterinary Medicines Regulations 2013”., 
## PART 4Medical devices, 
### CHAPTER 1Regulations: general, 
#### 15Power to make regulations about medical devices, 
(1)The Secretary of State may by regulations make provision specified insections 16 to 18 amending or supplementing the Medical Devices Regulations2002 ([S.I. 2002/618](/id/uksi/2002/618?view=plain "Go to item oflegislation"))., 
(2)In making regulations under subsection (1), the Secretary of State’soverarching objective must be safeguarding public health., 
(3)In considering whether regulations under subsection (1) would contribute tothis objective, the Secretary of State must have regard to—, 
(a)the safety of medical devices;, 
(b)the availability of medical devices;, 
(c)the likelihood of the United Kingdom being seen as a favourable place inwhich to—, 
(i)carry out research relating to medical devices,, 
(ii)develop medical devices, or, 
(iii)manufacture or supply medical devices., 
(4)Where regulations under subsection (1) may have an impact on the safety ofmedical devices, the Secretary of State may make the regulations only if theSecretary of State considers that the benefits of doing so outweigh the risks., 
#### 16Manufacture, marketing and supply, 
(1)Regulations under section 15(1) may make provision about—, 
(a)requirements that must be met in relation to medical devices in order forthem to be marketed, put into service or otherwise supplied (“relevantrequirements”), including—, 
(i)requirements in terms of design, manufacture, composition or othercharacteristics of the devices, or, 
(ii)requirements imposed on persons involved in marketing or supplying thedevices,, 
(b)assessments of whether relevant requirements are met in relation to medicaldevices,, 
(c)who may carry out such assessments, including provision about theappointment of one or more persons (whether or not established in the UnitedKingdom) who meet criteria set out in the regulations—, 
(i)to assess whether relevant requirements are met, and, 
(ii)if appropriate, to confirm that they are,, 
(d)treating confirmation that relevant requirements are met given by one ormore persons who are not appointed under provision made in reliance onparagraph (c) in the same way as confirmation given by a person who is soappointed,, 
(e)the making of declarations confirming that relevant requirements are met,, 
(f)requirements that medical devices carry evidence that relevant requirementsare met, including evidence that confirmation has been given as mentioned inparagraph (c) or (d),, 
(g)the packaging of medical devices, and information, labelling orinstructions to be supplied on, with or in relation to them,, 
(h)one or more registers of medical devices, their manufacturers or theirsuppliers, including provision—, 
(i)conferring functions relating to establishing and maintaining a register,, 
(ii)requiring information in relation to a medical device to be entered in aregister, and, 
(iii)permitting or requiring some or all of the information entered in aregister to be made publicly available,, 
(i)investigations into or evaluations of the safety or performance, includingthe clinical effectiveness, of medical devices, or, 
(j)surveillance of the market in medical devices., 
(2)Provision made in reliance on subsection (1)(a) may (among other things)identify relevant requirements by reference to international agreements orstandards relating to the marketing or supply of medical devices, includingagreements or standards as they have effect from time to time., 
#### 17Fees, information, offences, 
(1)Regulations under section 15(1) may make provision—, 
(a)about the charging of fees in connection with the exercise of a functionconferred by a medical devices provision, including the charging of fees by aperson appointed under provision made in reliance on section 16(1)(c),, 
(b)about the recording of information regarding the safety and performance,including the clinical effectiveness, of medical devices, including the extentto which relevant requirements that apply in relation to the devices are met,, 
(c)permitting or requiring such information to be disclosed to the Secretaryof State or to a person appointed under provision made in reliance on section16(1)(c), or, 
(d)amending the Schedule to the Medical Devices Regulations 2002 ([S.I.2002/618](/id/uksi/2002/618?view=plain "Go to item of legislation")) insertedby Schedule 3 to this Act (list of regulations breach of which is an offenceunder regulation 60A)., 
(2)In this Part, “medical devices provision” means a provision in—, 
(a)regulations under section 15(1), or, 
(b)the Medical Devices Regulations 2002., 
#### 18Emergencies, 
(1)Regulations under section 15(1) may make provision about the disapplicationof a medical devices provision in circumstances which give rise to a need toprotect the public from a risk of serious harm to health., 
(2)Regulations made in reliance on subsection (1) may provide for thedisapplication to be subject to—, 
(a)conditions set out in the regulations;, 
(b)conditions set out in a protocol published by the Secretary of State., 
(3)Where regulations made in reliance on subsection (1) provide that theSecretary of State may publish a protocol setting out conditions, theregulations must provide—, 
(a)that the Secretary of State may withdraw or amend the protocol, and, 
(b)that the protocol is to have effect only for a period of time specified inthe protocol., 
### CHAPTER 2Regulations: information systems, advisory committee, 
#### 19Information systems, 
(1)The Secretary of State may by regulations make provision about theestablishment and operation by the Health and Social Care Information Centre(“the Information Centre”) of one or more information systems for purposesrelating to—, 
(a)the safety and performance, including the clinical effectiveness, ofmedical devices that are placed on the market;, 
(b)the safety of individuals who receive or are treated with a medical device,or into whom a medical device is implanted;, 
(c)the improvement of medical device safety and performance through advancesin technology., 
(2)The regulations may (among other things) make provision—, 
(a)specifying descriptions of information in relation to medical devices whichmay or must be entered or retained in an information system established undersubsection (1);, 
(b)requiring information to be provided to the Information Centre for thepurposes of its functions under the regulations;, 
(c)about the use or disclosure of information contained in an informationsystem established under subsection (1);, 
(d)requiring the Information Centre to have regard to specified matters inexercising its functions under the regulations., 
(3)The provision mentioned in subsection (2)(b) may include provision—, 
(a)requiring specified persons or descriptions of persons to whom subsection(4) applies to provide information of a specified description to theInformation Centre;, 
(b)about the manner in which, and the time at which, those persons mustprovide that information;, 
(c)enabling the Information Centre to require specified persons ordescriptions of persons to whom subsection (4) applies to provide to it in amanner, and at a time, determined by the Information Centre—, 
(i)information of a specified description;, 
(ii)information for specified purposes;, 
(iii)any other information that the Information Centre considers it necessaryor expedient to have for the purposes of its functions under the regulations;, 
(d)about any procedural steps the Information Centre must follow in requiringa person to provide information to it;, 
(e)requiring specified persons or descriptions of persons to whom subsection(4) applies to record or retain information which they are, or may be,required to provide to the Information Centre under the regulations;, 
(f)in relation to the enforcement of any requirement imposed by or under theregulations., 
(4)This subsection applies to any person who provides services, or exercisesany powers or duties, relating to medical devices., 
(5)The descriptions of information specified in the provision mentioned insubsections (2)(a), (3)(a) and (3)(c)(i) may include—, 
(a)unique identifiers associated with medical devices;, 
(b)information in relation to individuals mentioned in subsection (1)(b);, 
(c)information about any procedure carried out in relation to a medical device(including information about any person involved in carrying out theprocedure)., 
(6)The provision mentioned in subsection (2)(c) may include provision about—, 
(a)the analysis by the Information Centre of information contained in aninformation system (whether alone or in combination with other information)for the purposes mentioned in subsection (1) or for other purposes;, 
(b)the publication by the Information Centre of information contained in aninformation system;, 
(c)the disclosure (other than by way of publication) of information containedin an information system to specified persons or descriptions of persons, orfor specified purposes;, 
(d)the use or further disclosure by any person of information disclosed tothem under the regulations., 
(7)The provision mentioned in subsection (3)(f) may include provision applyingany provision of Chapter 3 of this Part (enforcement), with or withoutmodifications, in relation to a requirement imposed by or under theregulations., 
(8)In this section, “specified” means specified in regulations undersubsection (1)., 
#### 20Advisory committee, 
(1)The Secretary of State may by regulations establish, and make otherprovision about, a committee to advise the Secretary of State on such mattersrelating to medical devices as the regulations may specify., 
(2)The regulations may (among other things) make provision about—, 
(a)the membership of the committee;, 
(b)the establishment by the committee of sub-committees;, 
(c)matters to which the committee may, or must, have regard;, 
(d)cooperation between the committee and the Commission on Human Medicines,and other bodies with expertise in relation to medical devices., 
(3)The provision mentioned in subsection (2)(a) may include—, 
(a)provision about the number of members, their appointment, and thecircumstances in which a person ceases to be a member;, 
(b)requirements as to the independence of members from the Secretary of State;, 
(c)provision about the payment of remuneration and allowances to members., 
### CHAPTER 3Enforcement, 
#### Enforcement notices, 
##### 21Compliance notices, 
(1)This section applies where the enforcement authority has reasonable groundsto suspect that a person involved in marketing or supplying a medical deviceis not complying with a medical devices provision., 
(2)The enforcement authority may serve a notice (“a compliance notice”) on theperson—, 
(a)identifying the medical devices provision with which the person issuspected not to be complying,, 
(b)setting out the enforcement authority’s grounds for suspecting that theperson is not complying with the provision,, 
(c)requiring the person to comply with the provision within a specifiedperiod,, 
(d)requiring the person within a specified period to provide evidence to thesatisfaction of the enforcement authority that the person is complying withthe provision, and, 
(e)requiring the person within a specified period to take any other measuresthat may be specified in order to comply with the provision., 
(3)A period specified in reliance on subsection (2)(c), (d) or (e) must be aperiod of at least 28 days beginning with the day on which the notice isserved., 
(4)The enforcement authority may vary or revoke a compliance notice., 
(5)Where the person mentioned in subsection (1) is a manufacturer, a noticeunder subsection (2) may be served on the manufacturer or on another personwho has been designated by the manufacturer to act as the manufacturer’srepresentative (or both)., 
(6)In this section, “specified” means specified in the compliance notice., 
##### 22Suspension notices, 
(1)This section applies where the enforcement authority considers that it maybe necessary to restrict the availability of a medical device in order toprotect health or safety., 
(2)The enforcement authority may serve on a person a notice (“a suspensionnotice”) prohibiting the person from doing the following except with theconsent of the enforcement authority—, 
(a)supplying the medical device;, 
(b)offering to supply it;, 
(c)agreeing to supply it;, 
(d)exposing it for supply;, 
(e)possessing it for supply., 
(3)A suspension notice must—, 
(a)set out the enforcement authority’s grounds for considering that it may benecessary to restrict the availability of the medical device to which thenotice relates, and, 
(b)specify the period for which the notice has effect., 
(4)The period may not end more than 6 months after the day on which thesuspension notice is served., 
(5)The enforcement authority may—, 
(a)reduce the period for which a suspension notice has effect, or, 
(b)revoke a suspension notice., 
##### 23Safety notices, 
(1)The enforcement authority may serve on a person a notice (“a safetynotice”) imposing on the person prohibitions or requirements that theenforcement authority considers necessary to restrict the availability of amedical device in order to protect health or safety., 
(2)The prohibitions that may be imposed include prohibitions on doing any ofthe following except with the consent of the enforcement authority—, 
(a)supplying the medical device;, 
(b)offering to supply it;, 
(c)agreeing to supply it;, 
(d)exposing it for supply;, 
(e)possessing it for supply., 
(3)The requirements that may be imposed include requirements to—, 
(a)publish, at the person’s expense, one or more warnings, in such form andmanner and on such occasions as may be specified in the notice, about amedical device which the person supplies or has supplied;, 
(b)organise or cooperate with the enforcement authority in organising in suchmanner as may be specified in the notice, so far as reasonably practicable,the recall of the device to the person or to any other person identified inthe notice., 
(4)But a requirement to organise or cooperate in the recall of a device may beimposed on a person in reliance on subsection (3)(b) only if the enforcementauthority is satisfied that no alternative requirement would sufficientlyprotect health or safety as mentioned in subsection (1)., 
(5)A safety notice must set out the grounds on which the enforcement authorityconsiders it necessary to restrict the availability of the medical device towhich the notice relates., 
(6)The enforcement authority may vary or revoke a safety notice., 
(7)Subject to subsection (8), the enforcement authority may not serve a safetynotice on a person or vary a safety notice unless the enforcement authorityhas given the person a reasonable opportunity to make representations aboutthe need for, and the contents of, the proposed safety notice or, as the casemay be, proposed variation., 
(8)Subsection (7) does not apply where the enforcement authority considersthat there is an urgent need to make the proposed safety notice or variationin order to restrict the availability of the medical device to which theproposed safety notice or variation relates., 
##### 24Information notices, 
(1)This section applies where the enforcement authority considers that aperson has information which the enforcement authority needs for the purposeof deciding whether to—, 
(a)serve or revoke a compliance notice,, 
(b)serve or revoke a suspension notice, or, 
(c)serve, vary or revoke a safety notice., 
(2)The enforcement authority may serve on the person a notice (an “informationnotice”) requiring the person—, 
(a)to disclose to the enforcement authority information specified in thenotice, within a period specified in the notice, or, 
(b)to produce records specified in the notice at a time and place specified inthe notice, and to permit a person appointed by the enforcement authority totake copies of the records at that time and place., 
(3)A period specified in reliance on subsection (2)(a) must be a period of atleast 28 days beginning with the day on which the notice is served., 
(4)A time specified in reliance on subsection (2)(b) must be at least 28 daysafter the notice is served., 
(5)The enforcement authority may vary or revoke an information notice., 
##### 25Applications to set notices aside etc, 
(1)A person affected by a compliance, suspension or safety notice may apply tothe appropriate lower court (see section 42)—, 
(a)to set the notice aside, or, 
(b)to vary it., 
(2)A person on whom an information notice has been served may apply to theappropriate lower court—, 
(a)to set the notice aside, or, 
(b)to vary it as mentioned in subsection (8)., 
(3)An application under subsection (1) or (2) must be made within the periodof 28 days beginning with the day on which the notice to which it relates is—, 
(a)served, or, 
(b)varied by the enforcement authority., 
(4)The appropriate lower court may set aside a compliance, suspension, safetyor information notice only if satisfied—, 
(a)in respect of a compliance notice, that the person on whom the notice wasserved is complying with each medical devices provision with which the personwas suspected not to be complying,, 
(b)in respect of a suspension notice, that the notice is not necessary toprotect health or safety,, 
(c)in respect of a safety notice, that the prohibitions or requirements in thenotice are not necessary to protect health or safety, or, 
(d)in respect of an information notice, that the person on whom it has beenserved does not have the information or records specified in the notice., 
(5)The appropriate lower court may vary a compliance notice so that it doesnot apply in relation to a medical devices provision specified in the noticeif satisfied that the person on whom the notice was served is complying withthat provision., 
(6)The appropriate lower court may vary a suspension notice by reducing theperiod for which it is to have effect if satisfied that the period for whichit would otherwise have had effect was too long., 
(7)The appropriate lower court may vary a safety notice by removing aprohibition or requirement if satisfied that the prohibition or requirement isnot necessary to protect health or safety., 
(8)The appropriate lower court may vary an information notice so that it doesnot apply in relation to some of the information or records specified in thenotice if satisfied that the person on whom it was served does not have thatinformation or those records., 
(9)An order of the appropriate lower court varying or setting aside acompliance, suspension, safety or information notice may contain provisiondelaying the coming into force of the order pending the making anddetermination of an appeal under section 27., 
##### 26Compensation, 
(1)A person affected by a compliance, suspension or safety notice which theappropriate lower court varies or sets aside may apply to the appropriatelower court for an order requiring the enforcement authority to paycompensation in respect of loss or damage caused by reason of the notice., 
(2)An application under subsection (1) may be made at the same time as anapplication under section 25(1)., 
##### 27Further appeals, 
(1)A person aggrieved by a decision of the appropriate lower court on anapplication under section 25(1) or (2) or section 26(1) may appeal againstthat decision to the appropriate appeals court (see section 42)., 
(2)An appeal under subsection (1) must be made before the end of the period of28 days beginning with the day on which the decision to which it relates ismade., 
(3)The appropriate appeals court may make any order the court thinksappropriate., 
#### Offences, 
##### 28Offences, 
(1)A person commits an offence if the person breaches—, 
(a)a compliance notice,, 
(b)a suspension notice,, 
(c)a safety notice, or, 
(d)an information notice., 
(2)A person guilty of an offence under subsection (1) is liable—, 
(a)on summary conviction in England and Wales, to imprisonment for a term notexceeding 51 weeks, to a fine or to both;, 
(b)on summary conviction in Scotland or Northern Ireland, to imprisonment fora term not exceeding 6 months, to a fine not exceeding level 5 on the standardscale or to both., 
(3)In relation to an offence committed before the coming into force of section281(5) of the Criminal Justice Act 2003, the reference in subsection (2)(a) to51 weeks is to be read as a reference to 6 months., 
##### 29Defence of due diligence, 
(1)It is a defence for a person charged with an offence under section 28(1) toshow that the person took all reasonable steps and exercised all due diligenceto avoid commission of the offence., 
(2)If in any proceedings for such an offence the defence provided bysubsection (1) involves an allegation that the commission of the offence wasdue to—, 
(a)an act or default of another person, or, 
(b)reliance on information given by another person,, 
the defendant is not, without leave of the court, entitled to rely on thatdefence unless the requirement in subsection (3) is satisfied., 
(3)The requirement is that at least 7 clear days before the hearing of theproceedings the defendant has served on the prosecutor a notice giving suchinformation identifying or assisting in the identification of that otherperson as was then in the defendant’s possession., 
(4)A defendant is not entitled to rely on the defence provided by subsection(1) by reason of the defendant’s reliance on information supplied by anotherperson unless the defendant shows that it was reasonable in all thecircumstances to rely on the information, having regard in particular to—, 
(a)the steps which the defendant took or might reasonably have taken to verifythe information, and, 
(b)whether the defendant had any reason to disbelieve the information., 
(5)In the application of this section to Scotland—, 
(a)references to the defendant are to be read as references to the accused,and, 
(b)the reference in subsection (3) to “the hearing of the proceedings” is tobe read as a reference to “the trial diet”., 
##### 30Offences by bodies corporate, 
(1)Where an offence under section 28 committed by a body corporate or aScottish partnership is proved to have been committed with the consent orconnivance of, or to be attributable to any neglect on the part of, anofficer, the officer (as well as the body corporate or partnership) commitsthe offence and is liable to be proceeded against and punished accordingly., 
(2)In relation to a body corporate, “officer” means—, 
(a)a director, manager, secretary or other similar officer of the body, or, 
(b)a person purporting to act in any such capacity., 
(3)In subsection (2)(a), “director”, in relation to a body corporate whoseaffairs are managed by its members, means a member of the body corporate., 
(4)In relation to a Scottish partnership, “officer” means—, 
(a)a partner, or, 
(b)a person purporting to act as a partner., 
#### Civil sanctions, 
##### 31Civil sanctions, 
Schedule 2 makes provision for and relating to civil sanctions in relation tothe commission of offences to do with medical devices., 
#### Forfeiture, 
##### 32Forfeiture of medical devices, 
(1)The enforcement authority may apply to the appropriate lower court (seesection 42) for an order for the forfeiture of a medical device (a “forfeitureorder”) on the grounds that there has been a contravention of a medicaldevices provision in relation to the device., 
(2)The appropriate lower court may make a forfeiture order if satisfied thatthere has been such a contravention., 
(3)The enforcement authority must make reasonable efforts to give notice ofthe application to every person who the enforcement authority thinks is or maybe entitled to the device to which the application relates., 
(4)Each person claiming to be entitled to the device may—, 
(a)appear at the hearing of the application, or, 
(b)make written representations to the appropriate lower court in relation tothe application., 
(5)If the appropriate lower court decides to make a forfeiture order, thecourt may include in the order provision that the device to which the orderrelates is not to be forfeited before the appropriate time., 
(6)The enforcement authority may dispose of a forfeited device in whatever waythe enforcement authority thinks appropriate., 
(7)But the enforcement authority may not dispose of a forfeited device beforethe appropriate time., 
(8)In this section, the “appropriate time” is—, 
(a)the end of the period within which an appeal under section 33 may be madeagainst the order, or, 
(b)if such an appeal is made, the end of the day on which the appeal isfinally determined or otherwise disposed of., 
(9)In this section, persons “entitled to a device” are—, 
(a)if the device has not been seized by the enforcement authority, the personin possession of the device,, 
(b)if the device has been seized, the person from whom it was seized, or, 
(c)if different, any person to whom it belongs., 
##### 33Appeals against forfeiture decisions, 
(1)A person claiming to be entitled to a medical device which is subject to aforfeiture order may appeal against the decision to make the order., 
(2)The enforcement authority may appeal against a decision of the appropriatelower court to refuse an application for a forfeiture order., 
(3)An appeal under this section is to the appropriate appeals court (seesection 42)., 
(4)An appeal under this section must be made before the end of the period of28 days beginning with the day on which—, 
(a)the forfeiture order is made, or, 
(b)the application for a forfeiture order is refused., 
(5)Subject to subsection (6), the court hearing the appeal may make any orderthe court thinks appropriate., 
(6)If an appeal against a decision to make a forfeiture order is allowed, thecourt must, if the device to which the order relates has already beenforfeited, order it to be returned to a person entitled to it., 
(7)In this section, persons “entitled to a device” are—, 
(a)if the device has not been seized by the enforcement authority, the personin possession of the device,, 
(b)if the device has been seized, the person from whom it was seized, or, 
(c)if different, any person to whom it belongs., 
#### Recovery of expenses of enforcement, 
##### 34Recovery of expenses of enforcement, 
(1)This section applies where a court—, 
(a)convicts a person of an offence under section 28 or regulation 60A of theMedical Devices Regulations 2002 ([S.I. 2002/618](/id/uksi/2002/618?view=plain"Go to item of legislation")) (offence of breaching certain provisions in theRegulations) in relation to a medical device, or, 
(b)makes a forfeiture order under section 32 or 33(5) in relation to a medicaldevice., 
(2)The court may (in addition to any other order it may make as to costs orexpenses) order the person convicted or, as the case may be, a person fromwhom a device is seized or to whom it belongs to reimburse an enforcementauthority for any expenditure which the authority has incurred or may incur—, 
(a)in connection with any seizure or detention of the device by or on behalfof the authority, or, 
(b)in connection with giving effect to the forfeiture order., 
#### Recall of medical device by enforcement authority, 
##### 35Recall of medical device by enforcement authority, 
(1)This section applies where the enforcement authority considers that—, 
(a)it is necessary to restrict the availability of a medical device in orderto protect health or safety, and, 
(b)the device has already been supplied or made available to members of thepublic., 
(2)The authority may take such steps as it considers necessary to organise thereturn of the device to the authority or to another person (whether or not itissues a safety notice under section 23 requiring another person to organiseor cooperate in organising the recall of the device)., 
(3)The authority may take steps in reliance on subsection (2) only ifsatisfied that no alternative steps that did not involve recalling the devicewould sufficiently protect health or safety as mentioned in subsection (1)., 
#### Power of officer of Revenue and Customs to detain medical device, 
##### 36Power of officer of Revenue and Customs to detain medical device, 
(1)An officer of Revenue and Customs may seize an imported medical device anddetain it for not more than two working days in order to facilitate theexercise by an enforcement authority or an officer of an enforcement authorityof a function under—, 
(a)this Part,, 
(b)a medical devices provision, or, 
(c)Schedule 5 to the Consumer Rights Act 2015., 
(2)A device seized and detained under this section must be dealt with duringthe period of its detention in such manner as the Commissioners for HerMajesty’s Revenue and Customs may direct., 
(3)In subsection (1), the reference to two working days is a reference to aperiod of 48 hours calculated from the time when the device in question isseized but disregarding so much of any period as falls on a Saturday or Sundayor on Christmas Day, Good Friday or a day which is a bank holiday under theBanking and Financial Dealings Act 1971 in the part of the United Kingdomwhere the device is seized., 
##### 37Offence of obstructing an officer of Revenue and Customs, 
(1)A person commits an offence if the person intentionally obstructs anofficer of Revenue and Customs who is acting under section 36., 
(2)A person guilty of an offence under subsection (1) is liable—, 
(a)on summary conviction in England and Wales, to imprisonment for a term notexceeding 51 weeks, to a fine or to both;, 
(b)on summary conviction in Scotland or Northern Ireland, to imprisonment fora term not exceeding 6 months, to a fine not exceeding level 5 on the standardscale or to both., 
(3)In relation to an offence committed before the coming into force of section281(5) of the Criminal Justice Act 2003, the reference in subsection (2)(a) to51 weeks is to be read as a reference to 6 months., 
#### Civil proceedings, 
##### 38Civil proceedings, 
(1)An obligation imposed by a medical devices provision is to be treated as aduty owed to any person who may be affected by a breach of the obligation., 
(2)Accordingly, a breach of such an obligation gives rise to a right of actionfor breach of statutory duty., 
(3)Subsections (1) and (2) are subject to—, 
(a)a provision to the contrary in a medical devices provision, and, 
(b)the defences and other incidents applying to actions for breach ofstatutory duty., 
### CHAPTER 4Disclosure of information and consequential etc provision, 
#### Disclosure of information, 
##### 39Disclosure of information, 
(1)This section applies in relation to information which the Secretary ofState holds in connection with medical devices., 
(2)The Secretary of State may disclose information for the purpose of warningmembers of the public about concerns that the Secretary of State has inrelation to the safety of a medical device., 
(3)The Secretary of State may disclose information to a person who providesservices or exercises functions relating to medical devices for the purposesof—, 
(a)enabling or facilitating the exercise by the Secretary of State of afunction relating to medical devices;, 
(b)enabling or facilitating the exercise by another person of a functionrelating to medical devices;, 
(c)enabling or facilitating the provision of a service relating to medicaldevices by another person., 
(4)The Secretary of State may disclose information for the purposes of—, 
(a)civil proceedings;, 
(b)criminal investigations or proceedings., 
(5)The Secretary of State may disclose information to a relevant personoutside the United Kingdom where—, 
(a)the disclosure is required for the purpose of giving effect to aninternational agreement or arrangement concerning the regulation of medicaldevices, and, 
(b)the Secretary of State considers that the disclosure is in the publicinterest., 
(6)But subsection (5) does not authorise a disclosure of patient informationwithout the consent of the individual to whom that information relates., 
(7)The Secretary of State may not disclose commercially sensitive informationin reliance on subsection (2), (3), (4) or (5) unless the Secretary of State—, 
(a)considers that it is necessary to do so for one or more of the purposesmentioned in subsection (2), (3), (4) or (5), and, 
(b)is satisfied that the making of the disclosure is proportionate to what issought to be achieved by it., 
(8)Where information to which this section applies is disclosed to a person inreliance on subsection (3) or (4), the person may not use or further disclosethe information except—, 
(a)with the agreement of the Secretary of State and for a purpose mentioned insubsection (3) or (4), or, 
(b)in accordance with an enactment or order of a court or tribunal., 
(9)Except as provided by subsection (10), the disclosure of information inaccordance with this section does not breach—, 
(a)an obligation of confidence owed by the person making the disclosure, or, 
(b)any other restriction on the disclosure of the information (howeverimposed)., 
(10)Nothing in this section authorises a disclosure of information which—, 
(a)contravenes the data protection legislation (but in determining whether adisclosure would do so, take into account the powers conferred by thissection), or, 
(b)is prohibited by any of Parts 1 to 7 or Chapter 1 of Part 9 of theInvestigatory Powers Act 2016., 
(11)This section does not limit the circumstances in which information may bedisclosed under any other enactment or rule of law., 
(12)In this section—, 
  * “commercially sensitive information” means commercial information whose disclosure the Secretary of State thinks might significantly harm the legitimate business interests of the undertaking to which it relates; , 
  * “patient information” means information (however recorded) which— , 
(a), 
relates to—, 
(i), 
the physical or mental health or condition of an individual,, 
(ii), 
the diagnosis of an individual’s condition, or, 
(iii), 
an individual’s care or treatment,, 
or is (to any extent) derived directly or indirectly from information relatingto any of those matters, and, 
(b), 
identifies the individual or enables the individual to be identified (whetherby itself or in combination with other information);, 
  * “relevant person” means— , 
(a), 
the government of a country or territory outside the United Kingdom;, 
(b), 
a person who exercises functions on behalf of such a government;, 
(c), 
any other person who exercises functions or provides services relating tomedical devices in a country or territory outside the United Kingdom;, 
(d), 
an international organisation that exercises functions or provides servicesrelating to medical devices., 
##### 40Offences relating to information, 
(1)A person to whom information is disclosed under section 39 commits anoffence if the person uses or discloses that information in contravention ofsubsection (8) of that section., 
(2)A person to whom information is disclosed under regulations under section19 (information systems) commits an offence if the person uses or disclosesthat information in contravention of those regulations., 
(3)A person guilty of an offence under subsection (1) or (2) is liable—, 
(a)on summary conviction in England and Wales, to imprisonment for a term notexceeding 51 weeks, to a fine or to both;, 
(b)on summary conviction in Scotland or Northern Ireland, to imprisonment fora term not exceeding 6 months, to a fine not exceeding level 5 on the standardscale or to both., 
(4)In relation to an offence committed before the coming into force of section281(5) of the Criminal Justice Act 2003, the reference in subsection (3)(a) to51 weeks is to be read as a reference to 6 months., 
#### Consequential etc provision, 
##### 41Consequential and supplementary provision, 
(1)In the Consumer Protection Act 1987—, 
(a)in section 11 (safety regulations), in subsection (7), at the end insert—, 
“(e)medical devices.”;, 
(b)in section 19 (interpretation of Part 2), in subsection (1), at theappropriate place insert—, 
  * ““medical device” has the same meaning as in Part 4 of the Medicines and Medical Devices Act 2021;”., 
(2)In the Consumer Rights Act 2015, in Schedule 5 (investigatory powers etc)—, 
(a)in paragraph 10 (enforcer’s legislation: duties and powers mentioned inparagraph 9(1)(a)), at the appropriate place insert “regulation 61 of theMedical Devices Regulations 2002 ([S.I. 2002/618](/id/uksi/2002/618?view=plain"Go to item of legislation"))”;, 
(b)in the table in paragraph 11 (enforcer’s legislation), at the end insert—, 
“The Secretary of State, a local weights and measures authority in GreatBritain or a district council in Northern Ireland| Regulations made undersection 15(1) of the Medicines and Medical Devices Act 2021  ---|---  The Secretary of State, a local weights and measures authority in GreatBritain or a district council in Northern Ireland| Chapter 3 of Part 4 of theMedicines and Medical Devices Act 2021”;    (c)in paragraph 19 (exercise of powers in Part 4), after sub-paragraph (7)insert—, 
“(7A)A domestic enforcer may exercise the power in paragraph 30A (power todecommission or switch off fixed medical devices)—, 
(a)if an officer of the enforcer reasonably suspects a breach of the MedicalDevices Regulations 2002 ([S.I. 2002/618](/id/uksi/2002/618?view=plain "Go toitem of legislation")) or of regulations made under section 15(1) of theMedicines and Medical Devices Act 2021, and, 
(b)for the purpose of ascertaining (by means of testing or otherwise) whetherthere has been such a breach.”;, 
(d)after paragraph 30 insert—, 
“30A(1)The power in sub-paragraph (2) is available to an officer of a domesticenforcer acting pursuant to the duty in regulation 61(1A) or (1B) of theMedical Devices Regulations 2002 ([S.I. 2002/618](/id/uksi/2002/618?view=plain"Go to item of legislation")) or to a duty in regulations made under section15(1) of the Medicines and Medical Devices Act 2021., 
(2)The officer may decommission or switch off any medical device to which theMedical Devices Regulations 2002 apply which is installed at a givenlocation.”;, 
(e)in paragraph 31 (power to break open container etc)—, 
(i)in sub-paragraph (1), for “30” substitute “30A”;, 
(ii)in sub-paragraph (2), for “30” substitute “30A”., 
(3)The Medical Devices Regulations 2002 ([S.I.2002/618](/id/uksi/2002/618?view=plain "Go to item of legislation")) areamended in accordance with subsections (4) to (7)., 
(4)In regulation 2 (interpretation), in paragraph (1) omit the definition of“the 1987 Act”., 
(5)Omit regulation 3B (confidentiality)., 
(6)In regulation 61 (enforcement and the Consumer Protection Act 1987 etc),for paragraphs (1) to (8) substitute—, 
“(1A)It is the duty of the Secretary of State to enforce these regulations inrelation to relevant devices and devices for performance evaluation., 
(1B)It is the duty of each weights and measures authority in Great Britain andeach district council in Northern Ireland to enforce these regulations withinits area (concurrently with the Secretary of State) in relation to relevantdevices that are ordinarily intended for private use or consumption., 
(1C)Nothing in this regulation authorises a weights and measures authority tobring proceedings in Scotland for an offence.”, 
(7)Omit—, 
(a)regulation 62 (compliance notices),, 
(b)regulation 63 (restriction notices), and, 
(c)regulation 64 (notification of decisions etc)., 
(8)As a result of the amendments made by subsections (1), (4), (6) and (7),the Medical Devices Regulations 2002 are not to be recognised as safetyregulations for the purposes of the Consumer Protection Act 1987, but thoseamendments do not otherwise affect the continued operation of thoseregulations., 
(9)Schedule 3 makes it an offence to breach various provisions in the MedicalDevices Regulations 2002., 
### CHAPTER 5Interpretation of Part 4, 
#### 42Interpretation of Part 4, 
(1)In this Part, apart from in sections 32, 33 and 34 (provisions relating toforfeiture or seizure of medical devices), references to a medical deviceinclude references to a type of medical device., 
(2)In this Part—, 
  * the “appropriate appeals court” means— , 
(a), 
in England and Wales, the Crown Court;, 
(b), 
in Scotland, the Sheriff Appeal Court;, 
(c), 
in Northern Ireland, a county court;, 
  * the “appropriate lower court” means— , 
(a), 
in England and Wales, a magistrates’ court;, 
(b), 
in Scotland, the sheriff;, 
(c), 
in Northern Ireland, a court of summary jurisdiction;, 
  * “compliance notice” has the meaning given by section 21(2); , 
  * “data protection legislation” has the meaning given by section 3(9) of the Data Protection Act 2018; , 
  * the “enforcement authority” means— , 
(a), 
in relation to medical devices which are ordinarily intended for private useor consumption—, 
(i), 
a local weights and measures authority in Great Britain or a district councilin Northern Ireland, or, 
(ii), 
the Secretary of State, or, 
(b), 
in relation to other medical devices, the Secretary of State;, 
  * “EU Medical Devices Regulations” means— , 
(a), 
[Regulation (EU) 2017/745](/european/regulation/2017/0745?view=plain "Go toitem of legislation") of the European Parliament and of the Council of 5 April2017 on medical devices, amending [Directive2001/83/EC](/european/directive/2001/0083?view=plain "Go to item oflegislation"), Regulation [(EC) No178/2002](/european/regulation/2002/0178?view=plain "Go to item oflegislation") and Regulation [(EC) No1223/2009](/european/regulation/2009/1223?view=plain "Go to item oflegislation") and repealing Council [Directives90/385/EEC](/european/directive/1990/0385?view=plain "Go to item oflegislation") and [93/42/EEC](/european/directive/1993/0042?view=plain "Go toitem of legislation"), and, 
(b), 
[Regulation (EU) 2017/746](/european/regulation/2017/0748?view=plain "Go toitem of legislation") of the European Parliament and of the Council of 5 April2017 on in vitro diagnostic medical devices and repealing [Directive98/79/EC](/european/directive/1998/0079?view=plain "Go to item oflegislation") and [Commission Decision2010/227/EU](/european/decision/2010/0227?view=plain "Go to item oflegislation");, 
  * “forfeiture order” has the meaning given by section 32(1); , 
  * “information notice” has the meaning given by section 24(2); , 
  * “manufacture” includes assembly; , 
  * “manufacturer” means any person who is a manufacturer for the purposes of any provision in the Medical Devices Regulations 2002 ([S.I. 2002/618](/id/uksi/2002/618?view=plain "Go to item of legislation")); , 
  * “medical device” includes— , 
(a), 
medical devices to which the Medical Devices Regulations 2002 apply, and, 
(b), 
devices to which the EU Medical Devices Regulations apply;, 
  * “medical devices provision” has the meaning given by section 17(2); , 
  * “relevant requirements” has the meaning given by section 16(1)(a); , 
  * “safety notice” has the meaning given by section 23(1); , 
  * “suspension notice” has the meaning given by section 22(2). , 
## PART 5Regulations under Parts 1, 2, 3 and 4, 
### 43Power to make consequential etc provision, 
(1)This section applies to regulations under a power in Part 1, 2, 3 or 4,apart from regulations under paragraph 9 of Schedule 2., 
(2)The regulations may—, 
(a)make consequential, supplementary, incidental, transitional, transitory orsaving provision;, 
(b)make different provision for different purposes;, 
(c)make different provision for different areas;, 
(d)make provision for all cases to which the power applies or for those casessubject to specified exceptions or for any specified cases or descriptions ofcase., 
### 44Scope of powers of Northern Ireland departments, 
No provision may be made by a Northern Ireland department acting alone inregulations under section 2(1) or 10(1) unless the provision, if it werecontained in an Act of the Northern Ireland Assembly—, 
(a)would be within the legislative competence of the Assembly, and, 
(b)would not require the consent of the Secretary of State., 
### 45Consultation, 
(1)Before making regulations under a provision of Part 1, 2, 3 or 4, therelevant authority must carry out a public consultation., 
(2)In relation to proposed regulations under section 19(1), the Secretary ofState must specifically consult—, 
(a)the Welsh Ministers,, 
(b)the Scottish Ministers, and, 
(c)the Department of Health in Northern Ireland., 
(3)In relation to proposed regulations under section 2(1), 10(1) or 15(1), theconsultation document must include a summary of the relevant authority’sassessment of the matters mentioned in section 2, 10 or 15 (as the case maybe)., 
(4)The duty to consult imposed by subsection (1) does not apply in relation toregulations that contain only provision made in reliance on—, 
(a)section 7 (disapplication of provisions relating to human medicines wherethere is a risk of serious harm to health), or, 
(b)section 18 (disapplication of provisions relating to medical devices wherethere is a risk of serious harm to health),, 
where the regulations contain a declaration that the person making themconsiders that they need to be made urgently to protect the public from animminent risk of serious harm to health., 
(5)The duty to consult imposed by subsection (1) may be satisfied byconsultation carried out before this Act was passed., 
(6)In this section, “the relevant authority” means—, 
(a)in relation to regulations made under section 2(1) or 10(1), theappropriate authority within the meaning given by section 2(6) or 10(6) as thecase may be, and, 
(b)in relation to any other regulations, the Secretary of State., 
### 46Reporting requirements, 
(1)As soon as reasonably practicable after the end of each reporting period,the relevant authority must lay before the appropriate legislature a report onthe operation of any regulations made by the relevant authority under sections2(1), 10(1), 15(1) and 19(1) that were in force at any time during thereporting period., 
(2)In preparing a report, the relevant authority must consult such persons asthe relevant authority considers appropriate., 
(3)A report must include a summary of—, 
(a)any concerns raised, or proposals for change made, by a person consulted inaccordance with subsection (2), and, 
(b)the relevant authority’s response to those concerns or proposals, includingany plan the relevant authority may have to make further regulations undersection 2(1), 10(1), 15(1) or 19(1)., 
(4)The reporting periods are—, 
(a)the period of 24 months beginning with the day on which the first set ofregulations under section 2(1), 10(1), 15(1) or 19(1) comes into force, and, 
(b)each successive period of 24 months., 
(5)In this section—, 
  * “appropriate legislature” means— , 
(a), 
in relation to a report of the Secretary of State, Parliament;, 
(b), 
in relation to a report of a Northern Ireland department, the Northern IrelandAssembly;, 
  * “relevant authority” means— , 
(a), 
in relation to regulations made under section 2(1) or 10(1) by the Secretaryof State (whether acting alone or jointly with a Northern Ireland department),the Secretary of State;, 
(b), 
in relation to regulations made under section 2(1) or 10(1) by a NorthernIreland department (whether acting alone or jointly with the Secretary ofState), the Northern Ireland department;, 
(c), 
in relation to regulations made under section 15(1) or 19(1), the Secretary ofState., 
### 47Procedure, 
(1)Any power to make regulations under a provision of Part 1, 2, 3 or 4 so faras exercisable by the Secretary of State, or by the Secretary of State actingjointly with a Northern Ireland department, is exercisable by statutoryinstrument., 
(2)Any power to make regulations under section 2(1) or 10(1) so far asexercisable by a Northern Ireland department (other than when acting jointlywith the Secretary of State) is exercisable by statutory rule for the purposesof the Statutory Rules (Northern Ireland) Order 1979 ([S.I. 1979/1573 (N.I.12)](/id/nisi/1979/1573?view=plain "Go to item of legislation")) (and not bystatutory instrument)., 
(3)The procedure for making regulations under Part 1, 2, 3 or 4 is to bedetermined in accordance with this table and subsection (4)—, 
If the regulations contain provision made in reliance on| the regulations aresubject to  ---|---  section 6(1)(a)| the negative procedure  section 12(1)(a)| the negative procedure  section 17(1)(a)| the negative procedure  paragraph 9 of Schedule 2| the negative procedure  section 7|, 
(a), 
the made affirmative procedure, where the regulations contain a declarationthat the person making them considers that they need to be made urgently toprotect the public from an imminent risk of serious harm to health, 
(b), 
the draft affirmative procedure in any other case    section 18|, 
(a), 
the made affirmative procedure, where the regulations contain a declarationthat the person making them considers that they need to be made urgently toprotect the public from an imminent risk of serious harm to health, 
(b), 
the draft affirmative procedure in any other case    any other provision of Part 1, 2, 3 or 4| the draft affirmative procedure    (4)Provision that may be made by regulations subject to the negative proceduremay be made by regulations subject to the draft affirmative procedure., 
(5)Where regulations are subject to “the negative procedure”—, 
(a)in the case of regulations made by the Secretary of State acting alone, thestatutory instrument containing the regulations is subject to annulment inpursuance of a resolution of either House of Parliament,, 
(b)in the case of regulations made by a Northern Ireland department actingalone, they are subject to negative resolution within the meaning given bysection 41(6) of the Interpretation Act (Northern Ireland) 1954, and, 
(c)in the case of regulations made by the Secretary of State and a NorthernIreland department acting jointly, the statutory instrument containing theregulations is subject to—, 
(i)annulment in pursuance of a resolution of either House of Parliament, and, 
(ii)negative resolution within the meaning given by section 41(6) of theInterpretation Act (Northern Ireland) 1954., 
(6)Where regulations are subject to the “draft affirmative procedure”—, 
(a)in the case of regulations made by the Secretary of State acting alone, thestatutory instrument containing the regulations may not be made unless a draftof the instrument has been laid before and approved by a resolution of eachHouse of Parliament,, 
(b)in the case of regulations made by a Northern Ireland department actingalone, they may not be made unless a draft of the regulations has been laidbefore and approved by a resolution of the Northern Ireland Assembly, and, 
(c)in the case of regulations made by the Secretary of State and a NorthernIreland department acting jointly, the statutory instrument containing theregulations may not be made unless a draft of the instrument has been laidbefore and approved by a resolution of—, 
(i)each House of Parliament, and, 
(ii)the Northern Ireland Assembly., 
(7)Where regulations are subject to the “made affirmative procedure”—, 
(a)in the case of regulations made by the Secretary of State acting alone, thestatutory instrument containing the regulations—, 
(i)must be laid before Parliament after being made, and, 
(ii)ceases to have effect at the end of the period of 40 days beginning withthe day on which the instrument is made unless, during that period, theinstrument is approved by a resolution of each House of Parliament,, 
(b)in the case of regulations made by a Northern Ireland department actingalone, they—, 
(i)must be laid before the Northern Ireland Assembly after being made, and, 
(ii)cease to have effect at the end of the period of 40 days beginning withthe day on which they are made unless, during that period, the regulations areapproved by a resolution of the Assembly, and, 
(c)in the case of regulations made by the Secretary of State and a NorthernIreland department acting jointly, the statutory instrument containing theregulations—, 
(i)must be laid before Parliament and the Northern Ireland Assembly afterbeing made, and, 
(ii)ceases to have effect at the end of the period of 40 days beginning withthe day on which the instrument is made unless, during that period, theinstrument is approved by a resolution of each House of Parliament and by aresolution of the Assembly., 
(8)In calculating the period of 40 days for the purposes of subsection(7)(a)(ii) or (c)(ii) in relation to Parliament, no account is to be taken ofany time during which—, 
(a)Parliament is dissolved or prorogued, or, 
(b)either House of Parliament is adjourned for more than 4 days., 
(9)In calculating the period of 40 days for the purposes of subsection(7)(b)(ii) or (c)(ii) in relation to the Northern Ireland Assembly, no accountis to be taken of any time during which the Assembly is—, 
(a)dissolved,, 
(b)in recess for more than 4 days, or, 
(c)adjourned for more than 6 days., 
(10)If regulations cease to have effect as a result of subsection (7) that—, 
(a)does not affect the validity of anything previously done under theregulations, and, 
(b)does not prevent the making of new regulations., 
## PART 6Report on operation of medicines and medical devices legislation, 
### 48Report on operation of medicines and medical devices legislation, 
(1)The Secretary of State must, before the end of the relevant period, publisha report on the operation of medicines and medical devices legislation., 
(2)The report must, in particular, include an assessment of whether—, 
(a)some or all medicines and medical devices legislation should beconsolidated or otherwise restructured,, 
(b)provisions of medicines and medical devices legislation should be includedin regulations or Acts of Parliament, and, 
(c)powers to make regulations should be modified or repealed., 
(3)In preparing the report, the Secretary of State must take into account anyreport relating to the operation of medicines and medical devices legislationmade by a Parliamentary Committee., 
(4)The Secretary of State must lay a copy of the report before Parliament., 
(5)In this section—, 
  * “medicines and medical devices legislation” means— , 
(a), 
the law relating to human medicines within the meaning of section 9(interpretation);, 
(b), 
the Veterinary Medicines Regulations 2013 ([S.I.2013/2033](/id/uksi/2013/2033?view=plain "Go to item of legislation"));, 
(c), 
the Medical Devices Regulations 2002 ([S.I.2002/618](/id/uksi/2002/618?view=plain "Go to item of legislation"));, 
(d), 
Parts 2 to 5 of this Act;, 
(e), 
regulations made under those Parts;, 
  * “Parliamentary Committee” means a committee of the House of Commons or of the House of Lords or a joint committee of both Houses; , 
  * “relevant period” means the period of 5 years beginning with the day on which this Act is passed. , 
## PART 7Extent, commencement and short title, 
### 49Extent, 
This Act extends to England and Wales, Scotland and Northern Ireland., 
### 50Commencement, 
(1)The following come into force on the day on which this Act is passed—, 
(a)this Part,, 
(b)section 2,, 
(c)section 6(4),, 
(d)section 7,, 
(e)section 9,, 
(f)section 15,, 
(g)section 17(2),, 
(h)section 18,, 
(i)section 42,, 
(j)Part 5, and, 
(k)Part 6., 
(2)The following come into force at the end of the period of two monthsbeginning with the day on which this Act is passed—, 
(a)Part 1,, 
(b)the remaining provisions of Part 2,, 
(c)Part 3,, 
(d)the remaining provisions of Chapter 1 of Part 4, and, 
(e)Chapter 2 of Part 4., 
(3)Chapters 3 and 4 of Part 4 (medical devices: enforcement and disclosure ofinformation) come into force on such day or days as the Secretary of State mayby regulations made by statutory instrument appoint., 
(4)Regulations may not be made in reliance on section 7 or 18 that come intoforce before the end of the period of two months beginning with the day onwhich this Act is passed unless they contain a declaration that the personmaking them considers that they need to be made urgently to protect the publicfrom an imminent risk of serious harm to health., 
### 51Transitional etc provision in connection with commencement, 
(1)The Secretary of State may by regulations made by statutory instrument maketransitional, transitory or saving provision in connection with the cominginto force of any provision of this Act (subject to subsection (4))., 
(2)The relevant Northern Ireland department may by regulations maketransitional, transitory or saving provision in connection with the cominginto force of Part 2 or, as the case may be, Part 3 so far as relating toNorthern Ireland., 
(3)No provision may be made by the relevant Northern Ireland department inregulations under subsection (2) unless the provision, if it were contained inan Act of the Northern Ireland Assembly—, 
(a)would be within the legislative competence of the Assembly, and, 
(b)would not require the consent of the Secretary of State., 
(4)Regulations of the Secretary of State under this section may not containprovision that could be made by regulations of the relevant Northern Irelanddepartment under this section., 
(5)The power to make regulations under subsection (2) is exercisable bystatutory rule for the purposes of the Statutory Rules (Northern Ireland)Order 1979 ([S.I. 1979/1573 (N.I. 12)](/id/nisi/1979/1573?view=plain "Go toitem of legislation"))., 
(6)In this section, the “relevant Northern Ireland department” means—, 
(a)in relation to Part 2, the Department of Health in Northern Ireland, and, 
(b)in relation to Part 3, the Department of Agriculture, Environment and RuralAffairs in Northern Ireland., 
### 52Short title, 
This Act may be cited as the Medicines and Medical Devices Act 2021., 
# SCHEDULES, 
Section 1, 
## SCHEDULE 1Further provision about the Commissioner for Patient Safety, 
### Principles relating to core duties, 
1(1)The Commissioner must prepare and publish a set of principles to governthe way in which the Commissioner will carry out the Commissioner’s coreduties., 
(2)The Commissioner—, 
(a)may revise the principles, and, 
(b)must publish any revised version., 
(3)The Commissioner must carry out a public consultation in preparing orrevising the principles., 
### Involvement of patients, 
2(1)The Commissioner must take reasonable steps to involve patients in thedischarge of the Commissioner’s core duties., 
(2)The Commissioner must in particular take reasonable steps to—, 
(a)ensure that patients are aware of the Commissioner’s core duties and of howthey may communicate with the Commissioner, and, 
(b)consult patients, or persons who appear to the Commissioner to representthe interests of patients, on matters which the Commissioner proposes toconsider in the discharge of the core duties., 
### Supplementary functions and information, 
3(1)For the purposes of carrying out the core duties, the Commissioner may—, 
(a)make a report or recommendation to a relevant person;, 
(b)consult or receive information from patients or any other person theCommissioner thinks appropriate;, 
(c)request information from a relevant person;, 
(d)share information with a relevant person., 
(2)A relevant person to whom a report or recommendation is made under sub-paragraph (1)(a) must provide a response to that report or recommendationwithin such period as the Commissioner may reasonably require., 
(3)A relevant person must, so far as reasonably practicable, comply with arequest by the Commissioner to provide information within such period as theCommissioner may reasonably require., 
(4)Nothing in this Schedule authorises a disclosure of information whichcontravenes the data protection legislation (but in determining whether adisclosure would do so, take into account the powers conferred by thisSchedule)., 
(5)In this paragraph—, 
  * “data protection legislation” has the meaning given by section 3(9) of the Data Protection Act 2018; , 
  * “health care” means all forms of health care provided for individuals, whether relating to physical or mental health, and including ancillary care; , 
  * “relevant person” means— , 
(a), 
a person who exercises functions of a public nature, relating to medicines ormedical devices, so far as those functions are exercisable in relation toEngland;, 
(b), 
any other person who, in the course of providing health care, providesservices relating to medicines or medical devices in relation to England., 
### Individual cases, 
4(1)The Commissioner may not exercise functions in relation to an individualcase., 
(2)But sub-paragraph (1) does not prevent the Commissioner consideringindividual cases and drawing conclusions about them for the purpose of, or inthe context of, considering a general issue., 
### Amendments to primary legislation, 
5(1)In Part 1 of the Table at the end of paragraph 3 of Schedule 1 to thePublic Records Act 1958 (definition of public records), at the appropriateplace insert—, 
  * “Commissioner for Patient Safety.”, 
(2)In Part 3 of Schedule 1 to the House of Commons Disqualification Act 1975(offices disqualifying for membership), at the appropriate place insert—, 
  * “Commissioner for Patient Safety.”, 
(3)In Part 6 of Schedule 1 to the Freedom of Information Act 2000 (otherpublic bodies and offices: general), at the appropriate place insert—, 
  * “The Commissioner for Patient Safety.”, 
(4)In section 71 of the National Health Service Act 2006 (schemes for meetinglosses and liabilities etc of certain health service bodies), in subsection(2), before paragraph (h) insert—, 
“(ga)the Commissioner for Patient Safety,”., 
(5)In Part 1 of Schedule 19 to the Equality Act 2010 (authorities subject tothe public sector equality duty), in the group of entries under the heading“Health, social care and social security”, at the appropriate place insert—, 
  * “The Commissioner for Patient Safety.”, 
### Regulations about appointment and operation, 
6(1)The Secretary of State may by regulations make such provision as theSecretary of State considers appropriate with regard to the appointment andoperation of the Commissioner., 
(2)Regulations under sub-paragraph (1) may (among other things) containprovision for and about—, 
(a)the Commissioner’s terms of office;, 
(b)remuneration or other benefits;, 
(c)the provision of financial or other assistance, including staff,accommodation, equipment or other facilities, for the Commissioner;, 
(d)requirements to prepare business plans;, 
(e)requirements to prepare reports;, 
(f)requirements to lay documents before Parliament;, 
(g)requirements to provide documents to the Secretary of State or otherpersons specified in the regulations;, 
(h)the conferring of functions on other persons in relation to theCommissioner;, 
(i)the appointment of a board to provide advice to the Commissioner., 
Section 31, 
## SCHEDULE 2Medical devices: civil sanctions, 
### PART 1Monetary penalties, 
#### Imposition of monetary penalty, 
1(1)The Secretary of State may impose a monetary penalty on a person ifsatisfied beyond reasonable doubt that the person has committed an offenceunder—, 
(a)section 28 (offence of breaching enforcement notice), or, 
(b)regulation 60A of the Medical Devices Regulations 2002 ([S.I.2002/618](/id/uksi/2002/618?view=plain "Go to item of legislation")) (offenceof breaching certain provisions in the Regulations)., 
(2)In this Schedule “monetary penalty” means a requirement to pay to theSecretary of State a penalty of an amount determined by the Secretary ofState., 
#### Notices, representations and appeals etc, 
2(1)Where the Secretary of State proposes to impose a monetary penalty on aperson, the Secretary of State must serve on the person a notice of what isproposed., 
(2)A notice under sub-paragraph (1) must offer the person the opportunity toavoid liability in relation to a monetary penalty by payment of a sumspecified in the notice (which must be less than or equal to the amount of thepenalty)., 
(3)The person may make written representations and objections to the Secretaryof State in relation to the proposed imposition of the monetary penalty., 
(4)After the end of the period for making such representations and objections(see paragraph 3(2)) the Secretary of State must decide whether to serve onthe person a notice imposing the monetary penalty., 
(5)The Secretary of State may not impose a monetary penalty on a person if theSecretary of State is no longer satisfied as mentioned in paragraph 1(1)., 
(6)A person on whom a monetary penalty is imposed may appeal against thedecision to impose the penalty on the ground—, 
(a)that the decision was based on an error of fact,, 
(b)that the decision was wrong in law,, 
(c)that the amount of the penalty is unreasonable, or, 
(d)that the decision is unfair, unreasonable or wrong for any other reason., 
(7)An appeal under sub-paragraph (6) is to the First-tier Tribunal., 
(8)Where an appeal is on the ground that the appellant did not commit anoffence as mentioned in paragraph 1(1), the Tribunal must allow the appealunless satisfied beyond reasonable doubt that the appellant committed theoffence in question, according to the same burden of proof as would apply ifthe Secretary of State were seeking to prove the matter in a criminalprosecution., 
#### Information to be included in notices under paragraph 2, 
3(1)A notice under paragraph 2(1) must include information as to—, 
(a)the grounds for the proposal to impose the monetary penalty;, 
(b)the effect of payment of the sum referred to in paragraph 2(2);, 
(c)the right to make representations and objections;, 
(d)the circumstances in which the Secretary of State may not impose themonetary penalty., 
(2)A notice under paragraph 2(1) must also specify—, 
(a)the period within which payment may be made so as to avoid liability for amonetary penalty, and, 
(b)the period within which representations and objections may be made., 
Neither period may be more than 28 days beginning with the day on which thenotice is served., 
(3)A notice under paragraph 2(4) imposing a monetary penalty must includeinformation as to—, 
(a)the grounds for imposing the monetary penalty;, 
(b)how payment may be made;, 
(c)the period within which payment is to be made;, 
(d)any early payment discounts or late payment penalties (including intereston payments);, 
(e)rights of appeal;, 
(f)the consequences of non-payment., 
The period referred to in paragraph (c) must be at least 28 days beginningwith the day on which the notice is served., 
#### Monetary penalties: criminal proceedings and conviction, 
4(1)Where a notice under paragraph 2(1) is served on a person—, 
(a)no criminal proceedings for an offence under section 28 or regulation 60Aof the Medical Devices Regulations 2002 may be instituted against the personin respect of the act or omission to which the notice relates before the endof the period within which the person’s liability may be discharged asmentioned in paragraph 2(2) (see paragraph 3(2)(a));, 
(b)if the liability is so discharged, the person may not at any time beconvicted of an offence under section 28 or regulation 60A of the MedicalDevices Regulations 2002 in relation to that act or omission., 
(2)A person on whom a monetary penalty is imposed may not at any time beconvicted of an offence under section 28 or regulation 60A of the MedicalDevices Regulations 2002 in respect of the act or omission giving rise to thepenalty., 
### PART 2Enforcement undertakings, 
5(1)This paragraph applies where—, 
(a)the Secretary of State has reasonable grounds to suspect that a person hascommitted an offence under section 28 or regulation 60A of the Medical DevicesRegulations 2002,, 
(b)the person offers an undertaking (an “enforcement undertaking”) to takespecified action within a specified period,, 
(c)the action specified is—, 
(i)action to secure that the offence does not continue or recur, or, 
(ii)action of a description set out in supplementary regulations (see Part 4of this Schedule), and, 
(d)the Secretary of State accepts the undertaking., 
(2)Unless the person fails to comply with the undertaking or any part of it—, 
(a)the person may not at any time be convicted of an offence under section 28or regulation 60A of the Medical Devices Regulations 2002 in respect of theact or omission to which the undertaking relates;, 
(b)the Secretary of State may not impose on the person any monetary penaltythat the Secretary of State would otherwise have power to impose by virtue ofparagraph 1 in respect of that act or omission., 
### PART 3Enforcement costs recovery notices, 
#### Imposition of enforcement costs recovery notices, 
6(1)The Secretary of State may serve an enforcement costs recovery notice on aperson on whom a monetary penalty has been imposed., 
(2)For the purposes of this Schedule an “enforcement costs recovery notice” isa notice requiring the person to pay to the Secretary of State the costsincurred by the Secretary of State in relation to the monetary penalty up tothe time when it was imposed., 
(3)In sub-paragraph (2), “costs” includes (in particular)—, 
(a)investigations costs;, 
(b)administration costs;, 
(c)costs of obtaining expert advice (including legal advice)., 
#### Information to be included in enforcement costs recovery notices, 
7(1)An enforcement costs recovery notice must specify the amount to be paidand must include information as to—, 
(a)the grounds for serving the notice;, 
(b)how payment may be made;, 
(c)the period within which payment is to be made;, 
(d)any early payment discounts or late payment penalties;, 
(e)rights to make written representations and objections in relation to theenforcement costs recovery notice;, 
(f)rights of appeal;, 
(g)the consequences of non-payment., 
The period referred to in paragraph (c) must be at least 28 days beginningwith the day on which the enforcement costs recovery notice is served., 
(2)A person required by an enforcement costs recovery notice to pay an amountto the Secretary of State may require the Secretary of State to provide adetailed breakdown of that amount., 
#### Appeals, 
8(1)A person served with an enforcement costs recovery notice may appealagainst the decision to serve it on the ground—, 
(a)that the decision was based on an error of fact,, 
(b)that the decision was wrong in law,, 
(c)that the decision was unreasonable, or, 
(d)that any of the costs to which the notice relates were unreasonablyincurred or unreasonable in amount,, 
or on any other grounds that are set out in supplementary regulations (seePart 4 of this Schedule)., 
(2)An appeal under sub-paragraph (1) is to the First-tier Tribunal., 
### PART 4Power to make supplementary provision etc by regulations, 
#### Supplementary regulations: general, 
9(1)The Secretary of State may by regulations (“supplementary regulations”)—, 
(a)make provision specified in paragraphs 10 to 12 supplementing that made bythis Schedule;, 
(b)make provision that is consequential on or incidental to that made by thisSchedule;, 
(c)make transitional, transitory or saving provision in relation to earliersupplementary regulations., 
(2)Regulations made under sub-paragraph (1) may—, 
(a)make different provision for different purposes;, 
(b)make different provision for different areas;, 
(c)make provision for all cases to which the power applies or for those casessubject to specified exceptions or for any specified cases or descriptions ofcase., 
#### Monetary penalties and costs, 
10(1)Supplementary regulations may make provision of any of the followingsorts in relation to the power of the Secretary of State to impose a monetarypenalty under paragraph 1 or costs under paragraph 6—, 
(a)provision for early payment discounts;, 
(b)provision for the payment of interest or other financial penalties for latepayment;, 
(c)provision for enforcement., 
(2)Provision made by virtue of sub-paragraph (1)(b) must secure that theinterest or other financial penalties for late payment do not in total exceedthe amount of the penalty or costs to which the interest or other financialpenalties relate., 
(3)Provision made by virtue of sub-paragraph (1)(c) may include—, 
(a)provision for the Secretary of State to recover the penalty or costs, andany interest or other financial penalty for late payment, as a civil debt;, 
(b)provision for the penalty or costs, and any interest or other financialpenalty for late payment, to be recoverable, on the order of a court, as ifpayable under a court order., 
#### Enforcement undertakings, 
11Supplementary regulations may make provision of any of the following sortsin relation to an enforcement undertaking—, 
(a)provision as to the procedure for entering into an undertaking;, 
(b)provision as to the terms of an undertaking;, 
(c)provision as to publication of an undertaking by the Secretary of State;, 
(d)provision as to variation of an undertaking;, 
(e)provision as to circumstances in which a person may be regarded as havingcomplied with an undertaking;, 
(f)provision as to monitoring by the Secretary of State of compliance with anundertaking;, 
(g)provision as to certification by the Secretary of State that an undertakinghas been complied with;, 
(h)provision for appeals against refusal to give such certification;, 
(i)in a case where a person has given inaccurate, misleading or incompleteinformation in relation to an undertaking, provision for the person to beregarded as not having complied with it;, 
(j)in a case where a person has complied partly but not fully with anundertaking, provision for that part-compliance to be taken into account inthe imposition of any criminal or other sanction on the person., 
#### Appeals, 
12(1)Supplementary regulations may make provision of any of the followingsorts in relation to an appeal in respect of the imposition of a requirementor the service of a notice under this Schedule—, 
(a)provision suspending the requirement or notice pending determination of theappeal (and providing for time during which the requirement or notice issuspended not to be taken into account in calculating any period of timerelating to the requirement or notice);, 
(b)provision as to the powers of the tribunal to which the appeal is made., 
(2)Provision made by virtue of sub-paragraph (1)(b) may (among other things)include provision conferring on the tribunal to which the appeal is made—, 
(a)power to withdraw the requirement or notice;, 
(b)power to confirm the requirement or notice;, 
(c)power to take any steps that the Secretary of State could take in relationto the act or omission giving rise to the requirement or notice;, 
(d)power to remit the decision whether to confirm the requirement or notice,or any matter relating to that decision, to the Secretary of State., 
### PART 5General and supplemental, 
#### Guidance as to enforcement, 
13(1)The Secretary of State must prepare and publish guidance as to—, 
(a)the sanctions that may be imposed on a person who commits an offence undersection 28 or regulation 60A of the Medical Devices Regulations 2002;, 
(b)the action that the Secretary of State may take in relation to such aperson;, 
(c)the circumstances in which the Secretary of State is likely to take anysuch action., 
(2)The guidance must include guidance about the Secretary of State’s use ofthe power to impose a monetary penalty, with information as to—, 
(a)the circumstances in which such a penalty may not be imposed;, 
(b)the amount of such a penalty;, 
(c)the matters likely to be taken into account by the Secretary of State indetermining that amount (including, where relevant, any discounts forvoluntary reporting of non-compliance);, 
(d)how liability for such a penalty may be discharged and the effect ofdischarge;, 
(e)rights to make representations and objections and rights of appeal inrelation to such a penalty., 
(3)The guidance must include guidance about the Secretary of State’s use ofthe power to serve an enforcement costs recovery notice, with information asto—, 
(a)the circumstances in which such a notice may not be served;, 
(b)the amount that a person may be required to pay;, 
(c)the matters likely to be taken into account by the Secretary of State indetermining that amount;, 
(d)how liability for the costs to which the notice relates may be dischargedand the effect of discharge;, 
(e)rights to make representations and objections and rights of appeal inrelation to those costs., 
(4)The guidance must include guidance about the Secretary of State’s use ofthe power to accept an enforcement undertaking., 
(5)Where appropriate, the Secretary of State must revise guidance publishedunder this paragraph and publish the revised guidance., 
(6)Before publishing guidance or revised guidance under this paragraph, theSecretary of State must consult—, 
(a)the Welsh Ministers, the Scottish Ministers and the Department of Health inNorthern Ireland, and, 
(b)any other persons the Secretary of State considers appropriate., 
(7)The Secretary of State must have regard to the guidance or revised guidancepublished under this paragraph in exercising functions under this Schedule., 
#### Pre-commencement consultation, 
14If, before the day on which this Schedule comes into force, any consultationwas undertaken which, had it been undertaken after that day, would to anyextent have satisfied the requirements of section 45 or paragraph 13, thoserequirements are to that extent to be taken to have been satisfied., 
#### Reports on use of civil sanctions, 
15(1)The Secretary of State must from time to time publish reports about theuse made by the Secretary of State of powers under this Schedule., 
(2)Each report must, in particular, specify—, 
(a)the cases in which a monetary penalty was imposed, or an enforcement costsrecovery notice was served, during the period to which the report relates(other than cases in which the penalty or notice was overturned on appeal);, 
(b)the cases in which liability for a monetary penalty was discharged asmentioned in paragraph 2(2);, 
(c)the cases in which an enforcement undertaking was accepted., 
(3)This paragraph does not require the Secretary of State to include in areport any information which, in the Secretary of State’s opinion, it would beinappropriate to include on the ground that doing so—, 
(a)would or might be unlawful, or, 
(b)might adversely affect any current investigation or proceedings., 
#### Disclosure of information, 
16(1)Information may be disclosed to the Secretary of State for the purpose ofthe exercise by the Secretary of State of any powers conferred on theSecretary of State under or by virtue of this Schedule if the information isheld by or on behalf of—, 
(a)a police officer or an officer of Revenue and Customs,, 
(b)the Crown Prosecution Service,, 
(c)a procurator fiscal, or, 
(d)the Public Prosecution Service for Northern Ireland., 
(2)It does not matter for the purposes of sub-paragraph (1) whether theinformation was obtained before or after this Schedule comes into force., 
(3)Subject to sub-paragraphs (4) and (5), the disclosure of information underthis paragraph is not to be taken to breach any restriction on the disclosureof information (however imposed)., 
(4)Nothing in this paragraph authorises a disclosure of information whichwould contravene the data protection legislation (but in determining whether adisclosure would do so, take into account the power conferred by thisparagraph)., 
(5)Nothing in this paragraph authorises a disclosure of information whichwould contravene Parts 1 to 7 or Chapter 1 of Part 9 of the InvestigatoryPowers Act 2016., 
(6)This paragraph does not affect a power to disclose information that existsapart from this paragraph., 
### PART 6Interpretation, 
17In this Schedule—, 
  * “enforcement costs recovery notice” has the meaning given by paragraph 6(2); , 
  * “enforcement undertaking” has the meaning given by paragraph 5(1)(b); , 
  * “monetary penalty” has the meaning given by paragraph 1(2); , 
  * “supplementary regulations” has the meaning given by paragraph 9. , 
Section 41, 
## SCHEDULE 3Offence of breaching provisions in the Medical DevicesRegulations 2002, 
### PART 1Offence, 
1In the Medical Devices Regulations 2002 ([S.I.2002/618](/id/uksi/2002/618?view=plain "Go to item of legislation")), afterregulation 60 insert—, 
#### “60AOffence of breaching certain provisions, 
(1)A person commits an offence if the person contravenes a prohibition orfails to comply with a requirement in a provision of the regulations listed inthe Schedule to these Regulations inserted by Schedule 3 to the Medicines andMedical Devices Act 2021., 
(2)A person guilty of an offence under paragraph (1) is liable—, 
(a)on summary conviction in England and Wales, to imprisonment for a term notexceeding 51 weeks, to a fine or to both;, 
(b)on summary conviction in Scotland or Northern Ireland, to imprisonment fora term not exceeding 6 months, to a fine not exceeding level 5 on the standardscale or to both., 
(3)In respect of an offence under this regulation—, 
(a)a magistrates’ court in England and Wales may try an information laidbefore the earlier of—, 
(i)the end of the period of one year beginning with the day on which evidencewhich the prosecutor thinks is sufficient to justify a prosecution comes tothe knowledge of the prosecutor, and, 
(ii)the end of the period of three years beginning with the day on which theoffence was committed;, 
(b)a magistrates’ court in Northern Ireland may hear and determine anycomplaint made before the earlier of—, 
(i)the end of the period of one year beginning with the day on which evidencewhich the prosecutor thinks is sufficient to justify a prosecution comes tothe knowledge of the prosecutor, and, 
(ii)the end of the period of three years beginning with the day on which theoffence was committed;, 
(c)in Scotland, summary proceedings for the offence may be commenced beforethe earlier of—, 
(i)the end of the period of one year beginning with the day on which evidencewhich the prosecutor thinks is sufficient to justify a prosecution comes tothe knowledge of the prosecutor, and, 
(ii)the end of the period of three years beginning with the day on which theoffence was committed., 
(4)For the purposes of paragraph (3)(a)(i), (b)(i) and (c)(i)—, 
(a)a certificate signed by or on behalf of the prosecutor and stating the dateon which such evidence came to the prosecutor’s knowledge is conclusiveevidence of that fact, and, 
(b)a certificate stating that matter and purporting to be so signed is to betreated as so signed until the contrary is proved., 
(5)In relation to an offence committed before the coming into force of section281(5) of the Criminal Justice Act 2003, the reference in paragraph (2)(a) to51 weeks is to be read as a reference to 6 months., 
#### 60BDefence of due diligence, 
(1)It is a defence for a person charged with an offence under regulation60A(1) to show that the person took all reasonable steps and exercised all duediligence to avoid commission of the offence., 
(2)If in any proceedings for such an offence the defence provided by paragraph(1) involves an allegation that the commission of the offence was due to—, 
(a)an act or default of another person, or, 
(b)reliance on information given by another person,, 
the defendant is not, without leave of the court, entitled to rely on thatdefence unless the requirement in paragraph (3) is satisfied., 
(3)The requirement is that at least 7 clear days before the hearing of theproceedings the defendant has served on the prosecutor a notice giving suchinformation identifying or assisting in the identification of that otherperson as was then in the defendant’s possession., 
(4)A defendant is not entitled to rely on the defence provided by paragraph(1) by reason of the defendant’s reliance on information supplied by anotherperson unless the defendant shows that it was reasonable in all thecircumstances to rely on the information, having regard in particular to—, 
(a)the steps which the defendant took or might reasonably have taken to verifythe information, and, 
(b)whether the defendant had any reason to disbelieve the information., 
(5)In the application of this regulation to Scotland—, 
(a)references to the defendant are to be read as references to the accused,and, 
(b)the reference in paragraph (3) to “the hearing of the proceedings” is to beread as a reference to “the trial diet”., 
#### 60COffences by bodies corporate, 
(1)Where an offence under regulation 60A(1) committed by a body corporate or aScottish partnership is proved to have been committed with the consent orconnivance of, or to be attributable to any neglect on the part of, anofficer, the officer (as well as the body corporate or partnership) commitsthe offence and is liable to be proceeded against and punished accordingly., 
(2)In relation to a body corporate, “officer” means—, 
(a)a director, manager, secretary or other similar officer of the body, or, 
(b)a person purporting to act in any such capacity., 
(3)In paragraph (2)(a), “director”, in relation to a body corporate whoseaffairs are managed by its members, means a member of the body corporate., 
(4)In relation to a Scottish partnership, “officer” means—, 
(a)a partner, or, 
(b)a person purporting to act as a partner.”, 
### PART 2Provisions, 
2In the Medical Devices Regulations 2002 ([S.I.2002/618](/id/uksi/2002/618?view=plain "Go to item of legislation")), afterthe last Schedule insert, with the appropriate number, the following Schedule—, 
Regulation 60A, 
#### “SCHEDULEProvisions breach of which is an offence under regulation 60A, 
The regulations referred to in regulation 60A(1) are—, 
Regulation| Description  ---|---  8(1), (2)| Essential requirements for general medical devices  10(1) to (5)| CE marking of general medical devices  11| CE marking of general medical devices within scope of more than oneDirective  13(1) to (4)| Procedures for affixing a CE marking to general medical devices  14(1), (2), (5)| Procedures for systems and procedure packs, and for devicesto be sterilised before use  15| Procedures for custom-made general medical devices  16(1), (4), (7), (10)| Procedures for general medical devices for clinicalinvestigation  17(1), (2)| Manufacturers etc and conformity assessment procedures for generalmedical devices  19| Registration of persons placing general medical devices on the market  22| Essential requirements for active implantable medical devices  24| CE marking of active implantable medical devices  25| CE marking of active implantable medical devices within scope of more thanone Directive  27| Procedures for affixing a CE marking to active implantable medical devices  28| Procedures for custom-made active implantable medical devices  29(1), (3), (6), (7), (9)| Procedures for active implantable medical devicesfor clinical investigations  30(1)| Manufacturers etc and conformity assessment procedures for activeimplantable medical devices  34| Essential requirements for in vitro diagnostic medical devices  36(1) to (5)| CE marking of in vitro diagnostic medical devices  37| CE marking of in vitro diagnostic medical devices within scope of morethan one Directive  38| In vitro diagnostic medical devices not ready for use  40| Procedures for affixing a CE marking to in vitro diagnostic medicaldevices  41(1), (2), (3)| Manufacturers etc and conformity assessment procedures for invitro diagnostic medical devices  43| Devices for performance evaluation  44| Registration of manufacturers etc of in vitro diagnostic medical devicesand devices for performance evaluation  50(1)(a) and (b), (2), (3)| Products incorrectly marked with a notified bodyor conformity assessment body number  51(1), (2)| Products incorrectly marked with a CE marking”, 
